✦ LIBER ✦

ChemInform Abstract: From ATP to AZD6140: The Discovery of an Orally Active Reversible P2Y12 Receptor Antagonist for the Prevention of Thrombosis.

✍ Scribed by Brian Springthorpe; et al. et al.

Publisher: John Wiley and Sons
Year: 2008
Weight: 19 KB
Volume: 39
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200807160

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

📜 SIMILAR VOLUMES

ChemInform Abstract: From Peptides to He

ChemInform Abstract: From Peptides to Heterocyclic Peptide Mimetics - Design and Synthesis of an Orally Active Fibrinogen Receptor Antagonist for the Prevention of Thrombosis.

✍ H. U. STILZ; G. BECK; B. JABLONKA; M. JUST 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 27 KB 👁 1 views

ChemInform Abstract: Discovery of an Ora

ChemInform Abstract: Discovery of an Orally-Active Nonsteroidal Androgen Receptor Pure Antagonist and the Structure—Activity Relationships of Its Derivatives.

✍ Kazutaka Tachibana; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views